Is it time to use real-world data from primary care in Alzheimer’s disease?

BACKGROUND: The analysis of real-world data in clinical research is rising, but its use to study dementia subtypes has been hardly addressed. We hypothesized that real-world data might be a powerful tool to update AD epidemiology at a lower cost than face-to-face studies, to estimate the prevalence...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponjoan, Anna, Garre-Olmo, Josep, Blanch, Jordi, Fages, Ester, Alves-Cabratosa, Lia, Martí-Lluch, Ruth, Comas-Cufí, Marc, Parramon, Dídac, Garcia-Gil, María, Ramos, Rafel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236302/
https://www.ncbi.nlm.nih.gov/pubmed/32423489
http://dx.doi.org/10.1186/s13195-020-00625-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236302/
https://www.ncbi.nlm.nih.gov/pubmed/32423489
http://dx.doi.org/10.1186/s13195-020-00625-2

Ejemplares similares